CD20‐TCB (RG6026), A NOVEL "2:1" FORMAT T‐CELL‐ENGAGING BISPECIFIC ANTIBODY, INDUCES COMPLETE REMISSIONS IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN'S LYMPHOMA. (12th June 2019) - Dickinson, M.J.; Morschhauser, F.; Iacoboni, G.; Carlo‐Stella, C.; Offner, F.C.; Sureda, A.; Salles, G.; Martinez, J.; Crump, M.; Thomas, D.N.; Morcos, P.N.; Ferlini, C.; et al.